Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) High-Performance Computing (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (2)
- Biology (2)
- Biomedical (2)
- Chemical Sciences (1)
- Computer Science (4)
- Coronavirus (2)
- Fusion (1)
- Materials (3)
- Materials Science (5)
- Microscopy (1)
- Nanotechnology (2)
- Neutron Science (14)
- Physics (1)
- Quantum Computing (1)
- Quantum Science (2)
- Space Exploration (1)
- Transportation (1)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.